Venous Thromboembolism Market
Venous thromboembolism occurs when a blood clot forms in a vein, obstructing the blood flow and posing a potentially life-threatening risk. Several devices and drugs are employed for the prevention and treatment of venous thromboembolism. The devices considered within this scope are utilized for both the prevention and treatment of venous thromboembolism and encompass compression pumps, thrombectomy devices, inferior vena cava filters, and stockings, among others.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
Venous Thromboembolism Treatment Market by Size, Share, Forecast, & Trends
Venous Thromboembolism Treatment Market to reach $4.40 billion by 2030 Meticulous Research a leading global market research company, published a research report titled, Venous Thromboembolism Treatment Market by Device (Thrombectomy, Inferior Vena Cava Filter [Retrievable, Permanent], Stockings, Compression Pump) Application (DVT, Pulmonary Embolism) End User (Hospital, Ambulatory Care Center) Global Forecast to 2030. Download Free sample Report Here: https://www.meticulousresearch.com/download-sample- report/cp_id=5745?utm_source=article&utm_medium=social+&utm_campaign=product&utm_content=23-04- 2024 According to this latest publication from Meticulous Research , the global venous thromboembolism treatment market is projected to reach $4.40 billion by 2030, at a CAGR of 7.2%. The high prevalence of venous thromboembolism, rising incidence of cancer, growing prevalence of secondary risk factors such as diabetes and obesity, increase in orthopedic surgical procedures, and the rising demand for minimally invasive treatment procedures are the key factors driving the growth of the venous thromboembolism treatment market. Furthermore, the growing accessibility and affordability of treatment options, advancements in VTE diagnosis and treatment methods, and the market expansion in emerging economies are expected to create market growth opportunities. However, instances of product failure and product recalls may restrain the market s growth. Additionally, lack of awareness about venous thromboembolism and increasing awareness of probable side effects of compression garments are major challenges for market growth. Top 10 companies: https://meticulousblog.org/top-10-companies-in-venous-thromboembolism- treatment-market/?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=23-04- 2024 Key Players The key players profiled in the venous thromboembolism treatment market report are ALN Implants chirurgicaux (ALN Surgical Implants) (France), AngioDynamics, Inc. (U.S.), Argon Medical Devices, Inc. (U.S.), ArjoHuntleigh AB (Sweden), Boston Scientific Corporation (U.S.), Cardinal Health, Inc. (U.S.), Cook Group Incorporated (U.S.), Koninklijke Philips N.V. (Netherlands), DS MAREF Co., LTD (South Korea), Enovis Corporation (U.S.), LifeTech Scientific Corporation (China), Medtronic plc (Ireland), and Stryker Corporation (U.S.). The global venous thromboembolism treatment market is segmented by device (thrombectomy devices, inferior vena cava filters {retrievable filters and permanent filters}, stockings, compression pumps, and other devices & accessories), application (deep vein thrombosis and pulmonary embolism), end user (hospitals, ambulatory care centers, and other end users), and geography. The study also evaluates industry competitors and analyzes the market at the global and regional levels. Page 1 of 2 Meticulous Research| sales@meticulousresearch.com
Venous Thromboembolism Treatment Market to reach $4.40 billion by 2030 Browse in depth: https://www.meticulousresearch.com/product/venous-thromboembolism-treatment- market-5745?utm_source=aarticle&utm_medium=social&utm_campaign=product&utm_content=23-04- 2024 Based on application, in 2023, the deep vein thrombosis segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the increasing geriatric population, rising cases of obesity, increasing cases of deep vein thrombosis due to disease-causing lifestyle, excessive alcohol consumption, and the growing awareness and early diagnosis of DVT. Obesity plays a significant role in the development of venous stasis, increasing the susceptibility to DVT. According to the World Health Organization (WHO), in 2021, the global prevalence of obesity exceeded 1 million individuals, encompassing 340 million adolescents, 650 million adults, and 39 million children. This number is expected to increase by about 167 million people, including adults and children, by 2025. Hence, the growing aging population and rising obesity rates are anticipated to drive the demand for devices aimed at preventing deep vein thrombosis during the forecast period .Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2022, North America is expected to account for the largest share of the venous thromboembolism treatment market, followed by Europe. Quick Buy: https://www.meticulousresearch.com/Checkout/77097308?utm_source=article&utm_medium=social+&utm_ campaign=product&utm_content=23-04-2024 Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 2 of 2 Meticulous Research| sales@meticulousresearch.com
